Theralase Technologies Inc. (TSXV:TLT)
0.1850
-0.0050 (-2.63%)
Apr 28, 2025, 3:59 PM EDT
Theralase Technologies Revenue
In the year 2024, Theralase Technologies had annual revenue of 1.03M CAD, down -3.45%. Theralase Technologies had revenue of 410.45K in the quarter ending December 31, 2024, with 12.88% growth.
Revenue
1.03M
Revenue Growth
-3.45%
P/S Ratio
44.54
Revenue / Employee
51.67K
Employees
20
Market Cap
46.03M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03M | -36.88K | -3.45% |
Dec 31, 2023 | 1.07M | -68.26K | -6.00% |
Dec 31, 2022 | 1.14M | 357.93K | 45.85% |
Dec 31, 2021 | 780.64K | -148.48K | -15.98% |
Dec 31, 2020 | 929.12K | -34.93K | -3.62% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
Trulieve Cannabis | 1.71B |
Extendicare | 1.47B |
WELL Health Technologies | 919.69M |
Curaleaf Holdings | 1.93B |
Cronos Group | 169.23M |
Theralase Technologies News
- 23 hours ago - Theralase Discovers New Mechanism of Action of Lead Drug - Newsfile Corp
- 14 days ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp
- 18 days ago - Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments - Newsfile Corp
- 21 days ago - Ruvidar Demonstrates 7 Year Complete Response - Newsfile Corp
- 5 weeks ago - Ruvidar Effective in the Treatment of Herpes - Newsfile Corp
- 5 weeks ago - Theralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Theralase(R) Releases 2024 Annual Financial Statements - Newsfile Corp
- 6 weeks ago - Theralase(R) Closes Non-Brokered Private Placement - Newsfile Corp